Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Other Non-Current Assets (2024 - 2026)

Updated

Hemab Therapeutics Holdings' Other Assets came in at $3.15 million for Q3 2026, up 37.8% from the prior quarter.

Analysis

Hemab Therapeutics Holdings (COAG) Other Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Hemab Therapeutics Holdings' Other Assets was $531,000, up 11.6% from FY2024.

  • Going back by year, Other Assets was $476,000 in FY2024.
  • The five-year range for quarterly Other Assets is $476,000 (Q4 2024) to $4.24 million (Q1 2026).
  • Business Quant data shows COAG's Other Assets at $2.29 million (Q2 2026), $4.24 million (Q1 2026) and $531,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 15.10 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 9.42 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 700.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 4.90 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 10.02 Bn
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn - 3.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.15 Mn
Jun 30, 2026 2.29 Mn
Mar 31, 2026 4.24 Mn
Dec 31, 2025 531,000.00
Dec 31, 2024 476,000.00
API Access

Hemab Therapeutics Holdings Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=COAG&period=max&api_key=YOUR_API_KEY